Abbvie reported $28.68B in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 452.98M 69.54M
Amgen AMGN:US $ 14842M 257M
Astrazeneca AZN:US $ 23649M 1427M
AstraZeneca AZN:LN 23649M 1427M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Chemocentryx CCXI:US $ 60.03M 4.65M
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Eisai 4523:JP Y 280829M 2895M
Eli Lilly And LLY:US $ 13682M 1411.2M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
Horizon Pharma HZNP:US $ 854.04M 1.23M
Infinity Pharmaceuticals INFI:US $ 12.35M 1.8M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Medtronic MDT:US $ 7803M 39M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NOVN:VX SF 29880M 247M
Pacira Pharmaceuticals PCRX:US $ 225.79M 2.9M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
United Therapeutics UTHR:US $ 320M 8.6M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Zoetis ZTS:US $ 1471M 620M